Michael Rudnick, MD

Renal Electrolyte and Hypertension
Accepting new patients
Sees patients age 18 and up
Penn Renal Electrolyte and Hypertension University City
Schedule onlineCall 800-789-7366
Penn Medicine Provider

About me

  • Chief, Section of Nephrology and Hypertension, Penn Presbyterian Medical Center
  • Associate Professor CE of Medicine (Renal-Electrolyte and Hypertension)

My education and training

  • Medical School: Drexel University College of Medicine
  • Residency: Hahnemann University Hospital
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

196 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
dr. rudnick is highly professional and very knowledgeable about my problems
Anonymous
April 2026
i would recommend him
Anonymous
April 2026
dr has a great bedside manner. he is vey thorough, patient ad understanding and an excellent and effective dr.
Anonymous
March 2026
he is sharp knowledgeable & good

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Rudnick is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Rudnick MR., Goldfarb S. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. [Review] [31 refs] , Reviews in Cardiovascular Medicine, 4 Suppl 5: 2003,S28-33

Wang A., Holcslaw T., Bashore TM., Freed MI., Miller D., Rudnick MR., Szerlip H., Thames MD., Davidson CJ., Shusterman N., Schwab SJ. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.[see comment] , Kidney International, 57(4): 2000,1675-80

Berns JS., Rudnick MR., Cohen RM., Bower JD., Wood BC. Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease , Kidney International, 56(1): 1999,253-60

Ermer JC., Boni JP., Cevallos WH., DeCleene S., Burghart P., Rudnick MR., Fruncillo RJ., Berns JS., Cohen RM. Bromfenac disposition in patients with impaired kidney function , Clinical Pharmacology & Therapeutics, 61(3): 1997,312-8

Rudnick MR., Berns JS., Cohen RM., Goldfarb S. Contrast media-associated nephrotoxicity. [Review] [150 refs] , Seminars in Nephrology, 17(1): 1997,15-26

Rudnick MR., Berns JS., Cohen RM., Goldfarb S. Contrast media-associated nephrotoxicity. [Review] [83 refs] , Current Opinion in Nephrology & Hypertension, 5(2): 1996,127-33

Berns JS., Haghighat A., Staddon A., Cohen RM., Schmidt R., Fisher S., Rudnick MR., Tomaszewski JE. Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients , Cancer, 76(3): 1995,497-500

Rudnick MR., Goldfarb S., Wexler L., Ludbrook PA., Murphy MJ., Halpern EF., Hill JA., Winniford M., Cohen MB., VanFossen DB. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study , Kidney International, 47(1): 1995,254-61

Revicki DA., Brown RE., Feeny DH., Henry D., Teehan BP., Rudnick MR., Benz RL. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients , American Journal of Kidney Diseases, 25(4): 1995,548-54

Roth D., Smith RD., Schulman G., Steinman TI., Hatch FE., Rudnick MR., Sloand JA., Freedman BI., Williams WW Jr., Shadur CA., et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients , American Journal of Kidney Diseases, 24(5): 1994,777-84